Hot Investor Mandate 4: China Seed Fund Seeks US Medtech, Mobile Health and Consumer Health Opportunities

9 Feb

An asset management firm that was founded in 2014 and is headquartered in Shanghai, China, is focused on angel and early stage investments in several industry sectors including healthcare. Typical investments range from US$0.2-2 million. The firm is open to leading or following in a financing round. The firm is looking for opportunities from China and the US.

The firm is interested in medical device, diagnostic, consumer and mobile health products that address pain points and rigid demand in the market and have unique entry barrier. The firm prefers products that have a short regulatory pathway to market. The firm typically invests in companies in seed and angel stages.

The firm works with teams with strong technical expertise and high growth potential. The firm is interested in overseas companies with a China angle and can provide technical, management, and distribution resources. The firm may request a board seat on a case-by-case basis.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: